GSRX Industries Inc

PINK:GSRX USA Drug Manufacturers - Specialty & Generic
Market Cap
$8.18K
Market Cap Rank
#48058 Global
#14796 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$19.00
About

GSRX Industries Inc., through its subsidiaries, engages in acquiring, developing, and operating retail cannabis dispensaries. It operates five cannabis dispensaries under the Green Spirit RX name in Puerto Rico; and a dispensary under The Green Room name in California. The company also owns and operates GetPureAndNatural.com, an e-commerce site that offers a range of hemp extract products. In add… Read more

GSRX Industries Inc (GSRX) - Net Assets

Latest net assets as of December 2020: $2.58 Million USD

Based on the latest financial reports, GSRX Industries Inc (GSRX) has net assets worth $2.58 Million USD as of December 2020.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.59 Million) and total liabilities ($3.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $2.58 Million
% of Total Assets 46.24%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 25.57

GSRX Industries Inc - Net Assets Trend (2006–2019)

This chart illustrates how GSRX Industries Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for GSRX Industries Inc (2006–2019)

The table below shows the annual net assets of GSRX Industries Inc from 2006 to 2019.

Year Net Assets Change
2019-12-31 $4.46 Million -43.36%
2018-12-31 $7.88 Million +7.79%
2017-12-31 $7.31 Million +1274.73%
2016-12-31 $-622.02K -16.49%
2015-12-31 $-533.99K -7056.06%
2007-12-31 $-7.46K -2684.33%
2006-12-31 $-268.00 --

Equity Component Analysis

This analysis shows how different components contribute to GSRX Industries Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 7857497100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2019)

Component Amount Percentage
Common Stock $81.80K 1.77%
Other Comprehensive Income $-264.58K -5.73%
Other Components $83.38 Million 1807.09%
Total Equity $4.61 Million 100.00%

GSRX Industries Inc Competitors by Market Cap

The table below lists competitors of GSRX Industries Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in GSRX Industries Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2018 to 2019, total equity changed from 7,474,354 to 4,613,816, a change of -2,860,538 (-38.3%).
  • Net loss of 36,257,003 reduced equity.
  • New share issuances of 1,183,000 increased equity.
  • Other comprehensive income decreased equity by 156,160.
  • Other factors increased equity by 32,369,625.

Equity Change Factors (2018 to 2019)

Factor Impact Contribution
Net Income $-36.26 Million -785.84%
Share Issuances $1.18 Million +25.64%
Other Comprehensive Income $-156.16K -3.38%
Other Changes $32.37 Million +701.58%
Total Change $- -38.27%

Book Value vs Market Value Analysis

This analysis compares GSRX Industries Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 $0.00 $0.00 x
2007-12-31 $-0.03 $0.00 x
2008-12-31 $-0.14 $0.00 x
2009-12-31 $-0.38 $0.00 x
2010-12-31 $-0.64 $0.00 x
2011-12-31 $-0.91 $0.00 x
2012-12-31 $-1.19 $0.00 x
2013-12-31 $-1.50 $0.00 x
2014-12-31 $-1.82 $0.00 x
2015-12-31 $-2.16 $0.00 x
2016-12-31 $-2.51 $0.00 x
2017-12-31 $0.37 $0.00 x
2018-12-31 $0.17 $0.00 x
2019-12-31 $0.07 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently GSRX Industries Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -785.84%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -329.48%
  • • Asset Turnover: 1.37x
  • • Equity Multiplier: 1.74x
  • Recent ROE (-785.84%) is below the historical average (-97.15%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 0.00% 0.00% 0.00x 0.00x $-4.24K
2007 0.00% 0.00% 0.00x 0.00x $-23.50K
2008 0.00% 0.00% 0.00x 0.00x $-47.10K
2009 0.00% 0.00% 0.00x 0.00x $-49.96K
2010 0.00% 0.00% 0.00x 0.00x $-47.57K
2011 0.00% 0.00% 0.00x 0.00x $-45.74K
2012 0.00% 0.00% 0.00x 0.00x $-40.35K
2013 0.00% 0.00% 0.00x 0.00x $-38.33K
2014 0.00% 0.00% 0.00x 0.00x $-34.50K
2015 0.00% 0.00% 0.00x 0.00x $-29.78K
2016 0.00% 0.00% 0.00x 0.00x $-25.84K
2017 -356.95% 0.00% 0.00x 1.03x $-26.81 Million
2018 -217.27% -605.60% 0.31x 1.15x $-16.99 Million
2019 -785.84% -329.48% 1.37x 1.74x $-36.72 Million

Industry Comparison

This section compares GSRX Industries Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
GSRX Industries Inc (GSRX) $2.58 Million 0.00% 1.16x $1.08K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million